Goodwin
Matthew Dunay
- Deals
- 2
- Latest
- Mar 2026
- Most deals in
- Biotech
Firm
- Goodwin Law firm · 2026 · 2 deals
Often works with
- Kingsley L. Taft 2 deals together
- Malhar Naik 2 deals together
- Arman Oruc 2 deals together
- Julie Tibbets 2 deals together
- Kevin Walsh 2 deals together
- Gozde Guckaya 2 deals together
- Samuel Beavers 1 deal together
- Sarah Solomon 1 deal together
Deals
Deals dated after 30 September 2026 are still being collected.
Columns
| Mar 2026 | Ouro Medicines | – | Gilead | Acquisition | Legal adviser to Ouro Medicines (target) | Announced | 1,675.0 | Biotech+1 | Gilead acquisition of Ouro Medicines |
| Mar 2026 | Pikavation | Synnovation | Novartis | Acquisition | Legal adviser to Synnovation Therapeutics (seller) | Announced | 2,000.0 | Biotech+2 | Novartis acquisition of Pikavation |
Deals where Matthew Dunay is named on the firm's deal team, by the firm or the press.